LASER PROPHYLAXIS IN STICKLER SYNDROME: The Manchester Protocol.


Journal

Retina (Philadelphia, Pa.)
ISSN: 1539-2864
Titre abrégé: Retina
Pays: United States
ID NLM: 8309919

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 03 07 2022
accepted: 17 09 2022
pubmed: 28 9 2022
medline: 24 12 2022
entrez: 27 9 2022
Statut: ppublish

Résumé

Patients with Stickler syndrome are at high risk of giant retinal tears (GRTs) and detachments. Vitreoretinal interventions can reduce this risk, but there is presently no consensus about the optimal prophylactic approach. The aim of our study was to determine whether 360° laser prophylaxis is a safe and effective procedure to prevent GRT detachments in patients with Stickler syndrome. Study subjects were recruited retrospectively through the databases of the vitreoretinal and ophthalmic genetic tertiary services in Manchester, United Kingdom. Clinical data were collected including on prophylactic intervention, the occurrence of retinal detachment, and the presence/type of retinal breaks. One hundred thirteen eyes from 63 patients with Stickler syndrome were studied; 72.6% (82/113) of these eyes received 360° laser prophylaxis. Of these, 9% had a retinal detachment, but no GRTs occurred. Among the 27.4% (31/113) of eyes that had no prophylactic treatment, 23% suffered a retinal detachment and 42.9% of these were associated with a GRT. Patients who underwent laser prophylaxis had fewer retinal detachments and no GRTs during an average of 6.1 years of follow-up (median 5 years), suggesting that this is a safe and effective approach for individuals with Stickler syndrome.

Identifiants

pubmed: 36165842
doi: 10.1097/IAE.0000000000003634
pii: 00006982-202301000-00012
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-93

Commentaires et corrections

Type : CommentIn

Références

Soh Z, Richards AJ, Mcninch A, et al. Dominant stickler syndrome. Genes 2022;13:1089.
Richards AJ, McNinch A, Martin H, et al. Stickler syndrome and the vitreous phenotype: mutations in COL2A1 and COL11A1. Hum Mutat 2010;31:E14671–E1471.
Nixon TRW, Richards AJ, Martin H, et al. Autosomal recessive stickler syndrome. Genes 2022;13:1135.
Coussa RG, Sears J, Traboulsi EI. Stickler syndrome: exploring prophylaxis for retinal detachment. Curr Opin Ophthalmol 2019;30:306–313.
Snead MP, McNinch AM, Poulson AV, et al. Stickler syndrome, ocular-only variants and a key diagnostic role for the ophthalmologist. Eye 2011;25:1389–1400.
Ang A, Poulson AV, Goodburn SF, et al. Retinal detachment and prophylaxis in type 1 Stickler syndrome. Ophthalmology 2008;115:164–168.
Fincham GS, Pasea L, Carroll C, et al. Prevention of retinal detachment in stickler syndrome: the Cambridge prophylactic cryotherapy protocol. Ophthalmology 2014;121:1588–1597.
Leiba H, Oliver M, Pollack A. Prophylactic laser photocoagulation in stickler syndrome. Eye 1996;10:701–708.
Carroll C, Papaioannou D, Rees A, et al. The Clinical Effectiveness and Safety of Prophylactic Retinal Interventions to Reduce the Risk of Retinal Detachment and Subsequent Vision Loss in Adults and Children with Stickler Syndrome: A Systematic Review. Southampton (UK): NIHR Journals Library; 2011. (Health Technology Assessment, No. 15.16.) 5, Discussion. Available at: https://www.ncbi.nlm.nih.gov/books/NBK99325/ .
Ripandelli G, Rossi T, Pesci FR. The prophylaxis of fellow-eye retinal detachment in stickler syndrome. A retrospective series. Retina 2022;42:250–255.
Rose PS, Levy HP, Liberfarb RM, et al. Stickler syndrome: clinical characteristics and diagnostic criteria. Am J Med Genet A 2005;138A:199–207.
Zimmerman J, Stubbs DJ, Richards AJ, et al. Stickler syndrome: airway complications in a case series of 502 patients. Anesth Analg 2021;132:202–209.
Chaudhary R, Dretzke J, Scott R, et al. Clinical and surgical risk factors in the development of proliferative vitreoretinopathy following retinal detachment surgery: a systematic review protocol. Syst Rev 2016;5:107.
Glaser BM, Vidaurri-Leal J, Michels RG, et al. Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells. Ophthalmology 1993;100:466–470.
Khanna S, Rodriguez SH, Blair MA, et al. Laser prophylaxis in patients with stickler syndrome. Ophthalmol Retina 2021. doi: 10.1016/j.oret.2021.11.001
doi: 10.1016/j.oret.2021.11.001
Morris RE, Parma ES, Robin NH, et al. Stickler syndrome (SS): laser prophylaxis for retinal detachment (modified ora secunda cerclage, OSC/SS). Clin Ophthalmol 2021;15:19–29.

Auteurs

Emma Linton (E)

Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Assad Jalil (A)

Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Panagiotis Sergouniotis (P)

Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Division of Evolution, Infection & Genomics, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, United Kingdom; and.
Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

George Moussa (G)

Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Graeme Black (G)

Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Division of Evolution, Infection & Genomics, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, United Kingdom; and.
Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Stephen Charles (S)

Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Tsveta Ivanova (T)

Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH